Received May 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Shingrix late second dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose in June 2024). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Shingrix late second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 29-APR-2025 Nurse practitioner wanted to obtain recommendations on a late second dose of Shingrix (the patient got the first dose in June 2024). Only the month in which the patient got vaccinated, her age and gender was provided. Till the time of reporting, the patient did not receive second dose of Shingrix, which led to incomplete course of vaccination.